Mr. Etienne Grima reports

CARDIOCOMM SOLUTIONS APPOINTS NEW CFO

Cardiocomm Solutions Inc. has appointed Robert Caines as chief financial officer of the company.

Effective Jan. 8, 2024, Mr. Caines assumed the role of chief financial officer, replacing Etienne Grima who served as interim chief financial officer since Aug. 3, 2023. Mr. Caines will also continue to serve as chairman of the board of directors and Mr. Grima will continue to serve as the company's chief executive officer.

The company has issued 250,000 stock options to Mr. Grima, the company's chief executive officer, in accordance with his employment agreement. The options are exercisable at five cents per share for five years from the date of grant and vest immediately. The grant is subject to the provisions of the company's stock option plan, the policies of the TSX Venture Exchange and applicable securities laws.

About Cardiocomm Solutions Inc.

Cardiocomm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American based sales team. Cardiocomm Solutions has earned the ISO 13485 and ISO 27001 certifications, is HIPAA (Health Insurance Portability and Accountability Act) compliant, and holds medical device clearances and sales licences from the United States (U.S. Food and Drug Administration) and Canada (Health Canada).

We seek Safe Harbor.